Acquired inhibitor of factor V: first report in China and literature review
Author:
Publisher
Wiley
Subject
Genetics (clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2004.01014.x/fullpdf
Reference18 articles.
1. Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure
2. Clinical and laboratory manifestations of anti-factor V antibodies
3. Severe Hemorrhagic Complication Due to Acquired Factor V Inhibitor After Single Exposure to Bovine Thrombin Product
4. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors
5. High-titer acquired factor V inhibitor responsive to corticosteroids and cyclophosphamide in a patient with two malignant tumors
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coagulation factor V inhibitors, a review of the case report literature;Thrombosis Update;2021-08
2. Acquired factor V inhibitor in a patient receiving venous-venous extracorporeal membrane oxygenation for Legionella pneumonia;Hong Kong Medical Journal;2015-04-02
3. Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature;Drug Design, Development and Therapy;2015-04
4. Acquired Inhibitors of Coagulation Factors: Part II;Seminars in Thrombosis and Hemostasis;2012-06-27
5. Inherited and acquired factor V deficiency;Blood Coagulation & Fibrinolysis;2011-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3